McKesson Stock Price, News & Analysis

McKesson Corporation (NYSE: MCK) has initiated a cash tender offer to purchase up to $500 million of its outstanding debt securities, including 6.00% Notes due 2041 and other series. The offer will expire on August 4, 2021, with an early tender deadline set for July 21, 2021. Holders of the notes must tender their securities by this date to receive an additional early tender payment of $50 per $1,000 principal. Pricing is based on U.S. Treasury yields plus additional fixed spreads. The company may extend or terminate the offer under specific conditions.

McKesson Corporation (NYSE: MCK) has agreed to sell its European operations in six countries, including France and Italy, to the PHOENIX group. The divestiture includes McKesson's German headquarters and various subsidiaries but excludes remaining operations in the UK and other Northern European countries. This strategic move aims to streamline McKesson's focus on growth outside Europe. The transaction is set to close in 2022, pending regulatory approvals. McKesson will discuss this sale further during its earnings call on August 4, 2021.

McKesson Corporation (NYSE: MCK) is set to release its first quarter fiscal 2022 financial results on August 4, 2021, after market close. A live webcast of the earnings conference call will be hosted at 4:30 PM ET, allowing investors to review the results. Interested parties can access the webcast on McKesson's Investor Relations website.

As a global leader in healthcare supply chain management and services, McKesson aims to innovate and provide effective healthcare solutions.

McKesson Corporation (NYSE:MCK) reported Q4 and FY21 results, showing FY21 revenues of $238.2 billion, a 3% increase. Q4 revenues were $59.1 billion, up 1%. Adjusted earnings per diluted share rose 15% for FY21 to $17.21. However, the company faced a significant loss of $28.26 per diluted share from continuing operations due to an $8.1 billion opioid-related liability. McKesson expects FY22 adjusted earnings per diluted share between $18.85 and $19.45, reflecting projected revenue growth of 3% to 6% and continued strong cash flow generation.

The Board of Directors of McKesson Corporation (NYSE: MCK) has declared a regular dividend of 42 cents per share of common stock. This dividend will be payable on July 1, 2021, to stockholders of record on June 1, 2021. McKesson is a leader in healthcare supply chain management and partners with various stakeholders in the healthcare sector to ensure safe and cost-effective distribution of medical products.

McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2021 financial results after market close on Thursday, May 6, 2021. The company will host a live webcast at 4:30 PM Eastern Time to discuss these results. Investors can access the webcast via McKesson's Investor Relations website, where additional financial information will also be available.

McKesson is recognized as a leader in healthcare supply chain management and has received multiple accolades, including being named a Most Admired Company in its industry.

McKesson Corporation (NYSE:MCK) reported third-quarter fiscal 2021 results, with revenues reaching $62.6 billion, a 6% increase from the previous year. Adjusted earnings per diluted share rose 21% to $4.60, driven by strong performance in U.S. Pharmaceuticals and Medical-Surgical Solutions segments. Despite an $8.1 billion pre-tax charge related to opioid litigation, the company successfully distributed COVID-19 vaccines and raised its adjusted earnings guidance for fiscal 2021 to $16.95-$17.25. The firm plans to repurchase an additional $2.0 billion in shares, reflecting confidence in its capital strategy.

The Board of Directors of McKesson Corporation (NYSE: MCK) announced a regular dividend of 42 cents per share. This dividend will be payable on April 1, 2021, to stockholders on record as of March 2, 2021. McKesson is recognized as a leader in healthcare supply chain management and has earned accolades such as being named a Most Admired Company in the healthcare sector by FORTUNE. The company is committed to providing essential healthcare solutions, ensuring timely access to medicines and medical products.

McKesson Corporation (NYSE:MCK) will announce its third quarter fiscal 2021 financial results on February 2, 2021, before market open. A live webcast of the earnings call will begin at 8:00 AM ET. The management will also participate in notable healthcare conferences, including the Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference on January 5, 2021, and the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021. Investors can access the webcast and financial materials on McKesson's Investor Relations website.